Efficacy and safety of switching from baricitinib to ritlecitinib in severe alopecia areata
- PMID: 39707907
- DOI: 10.1093/ced/llae548
Efficacy and safety of switching from baricitinib to ritlecitinib in severe alopecia areata
Conflict of interest statement
Conflicts of interest: The authors declare no conflicts of interest.
LinkOut - more resources
Full Text Sources
